News

Celebrate Innovation: AuditBoard Connector Awards Launch

Celebrate Innovation: AuditBoard Connector Awards Launch

Celebrate Innovation with the Launch of Connector Awards

Submissions now open for the AuditBoard Connector Awards.

AuditBoard, a leading cloud-based platform enhancing audit, risk, Environmental, Social, and Governance (ESG), and information security management, has unveiled its inaugural AuditBoard Connector Awards. This initiative aims to recognize and honor the trailblazers, innovators, and leaders who are shaping the future of audit, risk, and InfoSec. The call for submissions is now open, inviting entries until the deadline.

Purpose of the AuditBoard Connector Awards

The primary goal of the Connector Awards is to celebrate those who have significantly contributed to the field. AuditBoard highlights the importance of innovation in shaping how businesses approach audit and risk management. The awards aim to acknowledge outstanding efforts in these domains, underscoring success and improvements driven by technological integrations.

Key Award Categories

The AuditBoard Connector Awards will feature several categories designed to showcase diverse achievements:

  • Future Visionaries: Transforming the Industry With Innovation – These individuals and teams exemplify proactive approaches that have forged positive changes within their organization and the industry as a whole. Their implementation of AI, AuditBoard Analytics, and other innovative tools has set new standards for best practices.
  • Excellence in Action: Driving Impact and Transforming Business Performance – Organizations in this category have utilized AuditBoard to enhance operational efficiency and drive significant business outcomes, demonstrating the platform's power in meeting their goals.
  • Bridge Builders: Connecting Risk and Scaling Impact – This category recognizes those who effectively enhance collaboration among audit, risk, and compliance teams, facilitating better decision-making and breaking down operational silos.
  • Cyber GRC Trailblazer: Breaking Boundaries in Cyber Risk & Compliance Management – These companies utilize advanced technology, automation, and machine learning to bolster security, streamline compliance processes, and provide actionable insights for strategic business decisions.
  • Agent of Change: Leading With Vision and Impact – This individual stands out as a leader who not only influences their team's growth but also elevates the overall role of audit, risk, and compliance.

What Winners Will Gain

Winners of the Connector Awards will be revealed at the Audit & Beyond event, a premier gathering for professionals in audit, risk, and InfoSec management. This event is set to take place in an atmosphere of collaboration and insight sharing. The recognition granted through these awards signifies a noteworthy achievement, further enhancing the credibility and visibility of the recipients.

Quote from Leadership

Justin Greenberger, Chief Customer Officer at AuditBoard, expressed enthusiasm about the launch of the awards program, stating, "We are consistently inspired by the incredible initiatives undertaken by our customers. From reducing time spent on administrative tasks by 30-40% to saving thousands of hours on internal audit activities, the achievements of these organizations reflect the potential unlocked through the use of AuditBoard. We are eager to honor these remarkable contributions that push our industry forward."

About AuditBoard

AuditBoard stands at the forefront of transforming audit, risk management, compliance, and ESG processes in organizations. More than half of the Fortune 500 harness AuditBoard's capabilities to streamline their operations, achieving greater clarity and agility. The platform has received accolades for its customer satisfaction, ranking highly on G2 and Capterra. Additionally, Deloitte recognized AuditBoard as one of the fastest-growing technology companies in North America for multiple consecutive years.

Frequently Asked Questions

What are the AuditBoard Connector Awards?

These awards are designed to recognize individuals and organizations driving innovation and excellence in audit, risk, and InfoSec.

How can I submit a nomination for the awards?

Nominations can be submitted directly through AuditBoard's official website, where detailed instructions will be provided.

What categories are included in the Connector Awards?

The awards consist of categories that recognize visionaries, excellence, collaboration, cyber GRC, and influential leaders.

When are the winners announced?

The winners will be announced at an upcoming Audit & Beyond event, gathering leading professionals from the industry.

Why is AuditBoard significant in the industry?

AuditBoard is recognized for its innovative cloud-based platform that transforms how organizations manage audit and risk, with a strong customer satisfaction record.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 5

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading

Top 5 Most Recently Viewed Articles

XPENG Delivers 39,107 Vehicles in August 2026

Updated Category News Views 11

Grit and Green in XPENG's Latest Numbers You'd think someone at XPENG's HQ popped the champagne today, given what they're reporting, but don't let the buzz fool you. August 2026 saw them deliver 39,107 vehicles. That's a nice 4% tick up year over year. But remember, we're talking a sector where anything short of double digits can feel like a whisper instead of a roar....

Continue Reading
Artivion Set to Announce Financial Results in February 2026

Updated Category News Views 90

Artivion to Announce Fourth Quarter Financial Results Artivion, Inc. (NYSE: AORT), a renowned company in the cardiac and vascular sector, has set a date for the release of its fourth quarter financial results for the year 2025. The main announcement will occur on the afternoon of the market closing on February 12, 2026. This release is highly anticipated within investor...

Continue Reading
FibroBiologics and Charles River Unite for Cell Therapy Advancements

Updated Category News Views 181

FibroBiologics Partners with Charles River for Innovative Therapies FibroBiologics, Inc. (Nasdaq: FBLG), a pioneering biotechnology company, has announced a groundbreaking collaboration with Charles River Laboratories, a renowned name in drug discovery and manufacturing. This partnership aims to develop and manufacture advanced fibroblast cell-based therapies intended to...

Continue Reading
Axsome Therapeutics Looks Ahead with Participations in Events

Updated Category News Views 128

Axsome Therapeutics: Engaging the Investment Community Axsome Therapeutics, Inc. (NASDAQ: AXSM), a pioneering biopharmaceutical enterprise focused on revolutionary treatments for central nervous system (CNS) disorders, has exciting plans ahead as it prepares to engage with investors at significant upcoming conferences. This engagement highlights the company's commitment...

Continue Reading
Palmstreet's Bold Moves in the $68B Live Shopping Boom

Updated Category News Views 9

Palmstreet Sets the Stage for Seller Success As the live shopping phenomenon in the U.S. rivals the busiest stock market scramble, Palmstreet is laying down some serious game-changing strategies. We're staring at a market expected to hit a staggering $68 billion in 2026, more than doubling its size from three years ago. Instead of riding the coattails of this lucrative...

Continue Reading